Loading basket contents...
Human Papillomavirus (Preservcyt) (2 Challenges) EQA/PT Scheme
To assess the proficiency of laboratories in the detection of different high risk human papillomavirus (HPV) types within a PreservCyt® matrix.
Total Number of Challenges: 2
Number of Panel Members: 6
Distribution / Testing Period: Q1 & Q3
| Sample NA Target Source | Clinical material and/or cell lines containing HPV |
| Matrix Panel Format | Transport Medium (PreservCyt) |
| Panel Member Target Range | Covering clinical range |
| Panel Member Sample Volume | 4.0 ml |
| Panel Sample Pre-treatment Requirement | Ready for analysis. Treat as clinical samples and analyse accordingly. |
| Panel Analysis Type | Qualitative |
| Panel Testing | Evaluated by various molecular methodologies |
| Storage / Shipment Conditions | 15-30°C / Liquid Ambient |
| Accreditation / Regulatory Status | Accredited to ISO 17043 |
$1,228.58
